DK2421504T4 - Pædiatriske opløsninger omfattende propanolol - Google Patents

Pædiatriske opløsninger omfattende propanolol Download PDF

Info

Publication number
DK2421504T4
DK2421504T4 DK10717263.7T DK10717263T DK2421504T4 DK 2421504 T4 DK2421504 T4 DK 2421504T4 DK 10717263 T DK10717263 T DK 10717263T DK 2421504 T4 DK2421504 T4 DK 2421504T4
Authority
DK
Denmark
Prior art keywords
propanolol
pediatric
solutions including
solutions
pediatric solutions
Prior art date
Application number
DK10717263.7T
Other languages
English (en)
Other versions
DK2421504T3 (da
Inventor
Christine Chaumont
Elie Leverd
Valérie Muguet
Jean-François Cordoliani
Original Assignee
Pierre Fabre Dermatologie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40940328&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2421504(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pierre Fabre Dermatologie filed Critical Pierre Fabre Dermatologie
Application granted granted Critical
Publication of DK2421504T3 publication Critical patent/DK2421504T3/da
Publication of DK2421504T4 publication Critical patent/DK2421504T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Seasonings (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK10717263.7T 2009-04-21 2010-04-12 Pædiatriske opløsninger omfattende propanolol DK2421504T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09290298A EP2246044A1 (en) 2009-04-21 2009-04-21 Paediatric solutions comprising a beta-blocker
PCT/IB2010/051573 WO2010122442A1 (en) 2009-04-21 2010-04-12 Paediatric solutions comprising a beta-blocker

Publications (2)

Publication Number Publication Date
DK2421504T3 DK2421504T3 (da) 2017-05-01
DK2421504T4 true DK2421504T4 (da) 2022-11-14

Family

ID=40940328

Family Applications (2)

Application Number Title Priority Date Filing Date
DK12155472.9T DK2497461T4 (da) 2009-04-21 2010-04-12 Pædiatriske opløsninger omfattende en betablokker
DK10717263.7T DK2421504T4 (da) 2009-04-21 2010-04-12 Pædiatriske opløsninger omfattende propanolol

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK12155472.9T DK2497461T4 (da) 2009-04-21 2010-04-12 Pædiatriske opløsninger omfattende en betablokker

Country Status (32)

Country Link
US (2) US20120035270A1 (da)
EP (4) EP2246044A1 (da)
JP (1) JP5695029B2 (da)
KR (1) KR101713866B1 (da)
CN (1) CN102405041A (da)
AR (2) AR076338A1 (da)
AU (1) AU2010240551B2 (da)
BR (1) BRPI1015447B1 (da)
CA (1) CA2755175C (da)
CL (1) CL2011002634A1 (da)
CO (1) CO6410278A2 (da)
CY (2) CY1119390T1 (da)
DK (2) DK2497461T4 (da)
ES (2) ES2685178T5 (da)
GE (1) GEP20146087B (da)
HR (2) HRP20170610T4 (da)
HU (2) HUE034581T2 (da)
IL (1) IL214674A (da)
LT (2) LT2497461T (da)
MA (1) MA33003B1 (da)
MX (1) MX337463B (da)
NZ (1) NZ594592A (da)
PL (2) PL2421504T5 (da)
PT (2) PT2497461T (da)
RS (2) RS57668B2 (da)
RU (1) RU2011139233A (da)
SG (1) SG172960A1 (da)
SI (2) SI2497461T2 (da)
TN (1) TN2011000350A1 (da)
TW (1) TWI429459B (da)
UA (1) UA107570C2 (da)
WO (1) WO2010122442A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2246044A1 (en) 2009-04-21 2010-11-03 Pierre Fabre Dermo-Cosmétique Paediatric solutions comprising a beta-blocker
JP2019142972A (ja) * 2011-03-04 2019-08-29 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング タペンタドールの非経口的投与
MX369121B (es) 2011-03-04 2019-10-30 Gruenenthal Gmbh Formulacion farmaceutica acuosa de tapentadol para administracion oral.
MX348831B (es) * 2011-03-04 2017-06-30 Gruenenthal Gmbh Administración parenteral de tapentadol.
US9724297B2 (en) * 2014-04-01 2017-08-08 Arbor Pharmaceuticals, Inc. Sotalol compositions and uses of the same
TW201642843A (zh) 2015-03-27 2016-12-16 歌林達有限公司 他噴他多腸胃外給藥的穩定製劑
EP3515412B1 (en) 2016-09-23 2025-04-23 Grünenthal GmbH Stable formulation for parenteral administration of tapentadol
CN108261411B (zh) * 2016-12-30 2021-04-30 武汉科福新药有限责任公司 用于婴幼儿血管瘤治疗的口腔膜剂及其制备方法
CN107320467A (zh) * 2017-07-21 2017-11-07 江苏云阳集团药业有限公司 一种盐酸普萘洛尔药用组合物及其制备方法
CN108299279B (zh) * 2018-02-09 2021-03-23 北京梅尔森医药技术开发有限公司 取代芳基胺醇化合物及其制备方法和用途
US11547123B2 (en) * 2019-08-16 2023-01-10 The Folger Coffee Company Methods for reducing negative flavor attributes in coffee and compositions therefrom
US10610502B1 (en) * 2019-08-30 2020-04-07 Metacel Pharmaceuticals, LLC Oral baclofen solutions
TW202228662A (zh) 2020-09-30 2022-08-01 日商日產化學股份有限公司 含有水溶性β阻斷劑及卵磷脂之複合體
CN116407495A (zh) * 2023-03-09 2023-07-11 北京梅尔森医药技术开发有限公司 一种阿替洛尔口服溶液及其制备方法和应用
GB2628566A (en) 2023-03-29 2024-10-02 Novumgen Ltd An orally rapidly disintegrating tablet of propranolol and its process of preparation
AU2024352372A1 (en) 2023-09-30 2026-04-09 Liqmeds Worldwide Limited An oral liquid formulation of metoprolol
CN118021718B (zh) * 2024-04-12 2024-07-02 成都瑞尔医药科技有限公司 一种盐酸普罗帕酮注射液及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4600708A (en) 1985-07-19 1986-07-15 American Home Products Corporation Propranolol hydrochloride liquid formulations
HU209251B (en) * 1992-03-13 1994-04-28 Synepos Ag Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons
DE69613164T2 (de) 1995-03-15 2001-09-27 Kao Corp Verwendung eines Zusatzstoffes zur Verminderung von Bittergeschmack
JPH1025253A (ja) * 1996-07-12 1998-01-27 Kao Corp 苦味低減化剤及び苦味低減化法
JPH11349492A (ja) * 1998-06-03 1999-12-21 Yamanouchi Pharmaceut Co Ltd 苦味を低減した経口用医薬組成物および苦味低減化方法
JP2001342151A (ja) * 2000-03-31 2001-12-11 Eisai Co Ltd 甘味を有する薬剤組成物
BR0209973A (pt) * 2001-05-25 2004-04-06 Warner Lambert Co Composição farmacêutica lìquida
EP1543831A1 (en) * 2003-12-18 2005-06-22 Pfizer GmbH Arzneimittelwerk Gödecke Pregabalin composition
AU2005328349A1 (en) * 2005-02-25 2006-09-08 Biomarin Pharmaceutical Inc. Room temperature stable aqueous liquid pharmaceutical composition
AU2006251213A1 (en) * 2005-05-25 2006-11-30 Janssen Pharmaceutica N.V. Pediatric formulation of topiramate
DE102006020604A1 (de) * 2006-05-02 2007-11-08 Bayer Healthcare Ag Flüssige Arzneimittelformulierung
EP2050441A1 (en) 2007-10-19 2009-04-22 Université Victor Segalen Bordeaux 2 Use of beta blocker for the manufacture of a medicament for the treatment of hemangiomas
PL2268282T3 (pl) * 2008-04-25 2015-04-30 Apotex Tech Inc Płynny preparat deferypronu o przyjemnym smaku
EP2246044A1 (en) 2009-04-21 2010-11-03 Pierre Fabre Dermo-Cosmétique Paediatric solutions comprising a beta-blocker

Also Published As

Publication number Publication date
BRPI1015447A2 (pt) 2016-04-19
HRP20170610T4 (hr) 2022-12-09
RU2011139233A (ru) 2013-05-27
KR101713866B1 (ko) 2017-03-09
GEP20146087B (en) 2014-05-13
SI2497461T1 (sl) 2018-10-30
ES2623936T3 (es) 2017-07-12
IL214674A0 (en) 2011-09-27
CY1120667T1 (el) 2019-12-11
PL2497461T5 (pl) 2022-06-27
SI2421504T1 (sl) 2017-06-30
SI2497461T2 (sl) 2022-04-29
SG172960A1 (en) 2011-08-29
EP3384899A1 (en) 2018-10-10
MX2011010766A (es) 2011-10-21
MX337463B (es) 2016-03-07
NZ594592A (en) 2013-11-29
TWI429459B (zh) 2014-03-11
UA107570C2 (xx) 2015-01-26
CA2755175A1 (en) 2010-10-28
RS55862B1 (sr) 2017-08-31
US20120035270A1 (en) 2012-02-09
IL214674A (en) 2017-01-31
AU2010240551A1 (en) 2011-08-04
DK2497461T3 (da) 2018-09-03
AR117621A2 (es) 2021-08-18
BRPI1015447A8 (pt) 2017-10-03
EP2497461B1 (en) 2018-06-20
US20150087719A1 (en) 2015-03-26
AU2010240551B2 (en) 2015-07-16
TN2011000350A1 (en) 2013-03-27
EP2246044A1 (en) 2010-11-03
LT2421504T (lt) 2017-06-12
HUE039937T2 (hu) 2019-02-28
ES2685178T5 (es) 2022-04-13
ES2623936T5 (es) 2022-11-28
HRP20181408T1 (hr) 2018-11-02
CA2755175C (en) 2018-01-02
DK2497461T4 (da) 2022-02-14
RS57668B1 (sr) 2018-11-30
PL2421504T3 (pl) 2017-08-31
EP2497461A2 (en) 2012-09-12
MA33003B1 (fr) 2012-01-02
CN102405041A (zh) 2012-04-04
KR20120015305A (ko) 2012-02-21
CL2011002634A1 (es) 2012-06-08
HUE034581T2 (en) 2018-02-28
AR076338A1 (es) 2011-06-01
EP2421504A1 (en) 2012-02-29
BRPI1015447B1 (pt) 2020-01-28
EP2421504B1 (en) 2017-03-08
WO2010122442A1 (en) 2010-10-28
HRP20170610T1 (hr) 2017-07-28
PL2497461T3 (pl) 2018-12-31
JP5695029B2 (ja) 2015-04-01
TW201039862A (en) 2010-11-16
PL2421504T5 (pl) 2023-01-02
EP2497461B2 (en) 2021-12-15
CO6410278A2 (es) 2012-03-30
EP2497461A3 (en) 2014-01-01
CY1119390T1 (el) 2018-02-14
PT2497461T (pt) 2018-10-23
LT2497461T (lt) 2018-10-10
PT2421504T (pt) 2017-06-16
HRP20181408T4 (hr) 2022-03-04
JP2012524773A (ja) 2012-10-18
DK2421504T3 (da) 2017-05-01
RS57668B2 (sr) 2022-03-31
ES2685178T3 (es) 2018-10-05
RS55862B2 (sr) 2022-12-30
EP2421504B2 (en) 2022-08-10

Similar Documents

Publication Publication Date Title
NL301265I2 (nl) Quizartinib
EP2515984A4 (en) INTERFACE
BRPI1011694A2 (pt) similadores de categoria
NO20091729L (no) Nasal aspirator
DK2506766T3 (da) Åndedrætsovervågning
BRPI1008827A2 (pt) deisobutenizador
EP2413938A4 (en) INHIBITORS OF BINDING TO PROTEIN KINASE
DK2497461T4 (da) Pædiatriske opløsninger omfattende en betablokker
BRPI1014968A2 (pt) subalargador
DE112010002728A5 (de) Turboinhalator
EP2499707A4 (en) INTERFACE
DE112009005323A5 (de) Hebelarmprüfmaschine
DK2451354T3 (da) Lancet
DE112009005462T8 (de) Lenkungsssteuervorrichtung
BRPI1008070A2 (pt) tricianoboratos
BR112012004964A2 (pt) girocóptero
EP2440937A4 (en) A diagnostic method
BRPI1010159A2 (pt) bistuti
FI20096397A0 (fi) Ilmanvaihtolaite
IT1394992B1 (it) Dispositivo ossigenatore
BR112012003616A2 (pt) metilpirroloprimidinacarboxamidas
DE112010002351A5 (de) Klemmorrichtung
DK2459031T3 (da) Barneseng
DK2210985T3 (da) Forbindelsesindretning
DE102009053777A8 (de) Beschattungseinrichtung